CIK 0000728387 · Non-accelerated filer<br>Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 411458152
- Phone
- 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- Open-market buys, last 90 days
- $72,488
- in 2 filings
- Open-market sales, last 90 days
- $1,622,534
- in 5 filings
Net −$1,550,047. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-22 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase | +19,230 | $0.52 | $10K | 35,230 |
| 2020-10-22 | Austin Mark John Controller/Prin Fin&Acct Offic | Purchase · Warrant (right to buy) | +9,615 | 264,615 | ||
| 2020-10-22 | Krachon Michael EVP of Sales & Marketing | Purchase | +28,844 | $0.52 | $15K | 83,844 |
| 2020-10-22 | Krachon Michael EVP of Sales & Marketing | Purchase · Warrant (right to buy) | +14,422 | 689,422 | ||
| 2020-10-22 | Hunt Jonathan Robert Chief Financial Officer | Purchase | +67,306 | $0.52 | $35K | 67,306 |
| 2020-10-22 | Hunt Jonathan Robert Chief Financial Officer | Purchase · Warrant (right to buy) | +33,653 | 483,653 | ||
| 2020-10-22 | Cavanagh William Chief R&D Officer | Purchase | +7,692 | $0.52 | $4K | 27,692 |
| 2020-10-22 | Cavanagh William Chief R&D Officer | Purchase · Warrant (right to buy) | +3,846 | 705,506 | ||
| 2020-10-22 | McCormick Michael W Director | Purchase | +19,230 | $0.52 | $10K | 41,230 |
| 2020-10-22 | McCormick Michael W Director | Purchase · Warrant (right to buy) | +9,615 | 154,615 | ||
| 2020-10-22 | Hoffmann Alan Director | Purchase | +19,230 | $0.52 | $10K | 19,230 |
| 2020-10-22 | Hoffmann Alan Director | Purchase · Warrant (right to buy) | +9,615 | 154,615 | ||
| 2020-10-22 | Vitale Philip J Director | Purchase | +20,000 | $0.52 | $10K | 130,000 |
| 2020-10-22 | Vitale Philip J Director | Purchase · Warrant (right to buy) | +10,000 | 155,000 | ||
| 2020-10-22 | Woods Lori A CEO | Purchase | +48,076 | $0.52 | $25K | 48,076 |
| 2020-10-22 | Woods Lori A CEO | Purchase · Warrant (right to buy) | +24,038 | 611,538 | ||
| 2020-06-23 | McCormick Michael W Director | Grant or award · Stock Options (right to buy) | +30,000 | 145,000 | ||
| 2020-06-23 | Hoffmann Alan Director | Grant or award · Stock Options (right to buy) | +30,000 | 145,000 | ||
| 2020-06-23 | Vitale Philip J Director | Grant or award · Stock Options (right to buy) | +30,000 | 145,000 | ||
| 2020-06-23 | Krachon Michael EVP of Sales & Marketing | Grant or award · Stock Options (right to buy) | +150,000 | 675,000 |
Page 9 of 26 · 504 trades